COLLABORATIVE R&D AGREEMENTCollaborative R&d Agreement • July 31st, 2013
The Innovation, Impact and Knowledge Exchange (IIKE) support fund at the University of Sheffield has awarded funding to the above titled project attached as Annex 1 to [Principal Investigator Name] of the Department of [name] at the University of Sheffield (“the Project Lead”). The project involves commitment and collaboration from [Company Name] (“the Project Partner”). Each is hereafter referred to as a Party and together the Parties.
Collaborative R&D agreement for Azymetric platform for development of bi- specific antibody therapeutic candidatesCollaborative R&d Agreement • February 9th, 2022
Zymeworks has earned a milestone payment from Merck (known as MSD outside the US and Canada) achieved under the companies’ 2014 research and license agreement.
COLLABORATIVE R&D AGREEMENTCollaborative R&d Agreement • August 9th, 2020
The HEIF Collaborative R&D fund at the University of Sheffield has awarded funding to the above titled project attached as Annex 1 to [Principal Investigator Name] of the Department of [name] at the University of Sheffield (“the Project Lead”). The project involves commitment and collaboration from [Company Name] (“the Project Partner”). Each is hereafter referred to as a Party and together the Parties.
Collaborative R&D agreement for single G-protein coupled receptor (GPCR) discovery programCollaborative R&d Agreement • May 31st, 2021
Collaborative R&D agreement for asthma and COPD drug discovery platformsCollaborative R&d Agreement • August 5th, 2020
Collaborative R&D agreement for translational research for product developmentCollaborative R&d Agreement • June 1st, 2024
This marks the first industrial partnership for CTSI’s Catalyst Awards program’s therapeutic track, which focuses specifically on discovery and development of patient treatment options.
DealdocCollaborative R&d Agreement • February 10th, 2021
Collaborative R&D agreement for yeast-based antibody discovery platform to identify fully human antibodies (expanded)
Collaborative R&D agreement for regenerative medicine portfolioCollaborative R&d Agreement • June 16th, 2024
This agreement is an expansion of a long-standing collaboration which led to the development of C-Cure, Cardio3 BioSciences' product candidate now in advanced clinical trial testing (Phase III), an innovative cell therapy based on the discovery of the cardiopoiesis platform by the team at Mayo Clinic.
Collaborative R&D agreement for early discovery of new diseasesCollaborative R&d Agreement • August 28th, 2023
Agreement to be printed on Stamp PaperCollaborative R&d Agreement • March 26th, 2015 • Delhi
………….. by and between the ONGC Energy Centre Trust registered as a Trust and having one of its offices located at 2nd Floor, Core-2, SCOPE Minar, Laxmi Nagar, Delhi- 110092 (hereinafter called ‘OECT’, which expression shall unless repugnant to the context or meaning thereof include all its successors, administrators, executors and assignees) of the Party-1
Collaborative R&D agreement for antibody-drug conjugate (ADC) technology with antibodies to a single oncology targetCollaborative R&d Agreement • May 28th, 2021
Abbott Laboratories will pay a $25 million upfront fee to Seattle Genetics for expanded rights to utilize Seattle Genetics' technology for cancer.
Collaborative R&D agreement for early-stage diabetes researchCollaborative R&d Agreement • March 28th, 2022
The European Foundation for the Study of Diabetes (EFSD), JDRF and Eli Lilly and Company (NYSE: LLY) have agreed to extend their collaboration for the European Programme in Type 1 Diabetes Research through 2020.
Collaborative R&D agreement for I-STAR technology in infectious disease and cancer antibody discoveryCollaborative R&d Agreement • September 14th, 2021
COLLABORATIVE R&D AGREEMENTCollaborative R&d Agreement • November 13th, 2013
The Innovation, Impact and Knowledge Exchange (IIKE) support fund at the University of Sheffield has awarded funding to the above titled project attached as Annex 1 to PI of the Department of XXXXXXXXXXX at the University of Sheffield (“the Project Lead”). The project involves commitment and collaboration from Project Partner (“the Project Partner”). Each is hereafter referred to as a Party and together the Parties.
